Airija - anglų - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - pioglitazone hydrochloride - tablet - 45 milligram(s) - thiazolidinediones; pioglitazone

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

teva pharmaceuticals usa - pioglitazone hydrochloride (unii: jqt35npk6c) (pioglitazone - unii:x4ov71u42s) - pioglitazone 15 mg

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

rebel distributors corp. - pioglitazone hydrochloride (unii: jqt35npk6c) (pioglitazone - unii:x4ov71u42s) - pioglitazone hydrochloride 15 mg - actos is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. initiation of actos in patients with established new york heart association (nyha) class iii or iv heart failure is contraindicated (see boxed warning ).       actos is contraindicated in patients with known hypersensitivity to this product or any of its components.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

direct_rx - pioglitazone hydrochloride (unii: jqt35npk6c) (pioglitazone - unii:x4ov71u42s) - monotherapy and combination therapy pioglitazone tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings [see clinical studies (14)] . important limitations of use pioglitazone tablet exerts its antihyperglycemic effect only in the presence of endogenous insulin. pioglitazone tablets should not be used to treat type 1 diabetes or diabetic ketoacidosis, as it would not be effective in these settings. use caution in patients with liver disease [see warnings and precautions (5.3)] . initiation in patients with established nyha class iii or iv heart failure [see boxed warning]. use in patients with known hypersensitivity to pioglitazone or any other component of pioglitazone tablets. 8.1 pregnancy risk summary limited data with pioglitazone hydrochloride in pregnant women are not sufficient to determine a drug-associated risk for major birth defects or miscarriage. there are risks to the mother and fetus associ

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

directrx - pioglitazone hydrochloride (unii: jqt35npk6c) (pioglitazone - unii:x4ov71u42s) - monotherapy and combination therapy pioglitazone tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings [see clinical studies (14)] . important limitations of use pioglitazone tablet exerts its antihyperglycemic effect only in the presence of endogenous insulin. pioglitazone tablets should not be used to treat type 1 diabetes or diabetic ketoacidosis, as it would not be effective in these settings. use caution in patients with liver disease [see warnings and precautions (5.3)] . initiation in patients with established nyha class iii or iv heart failure [see boxed warning]. use in patients with known hypersensitivity to pioglitazone or any other component of pioglitazone tablets. 8.1 pregnancy risk summary limited data with pioglitazone hydrochloride in pregnant women are not sufficient to determine a drug-associated risk for major birth defects or miscarriage. there are risks to the mother and fetus associ

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

directrx - pioglitazone hydrochloride (unii: jqt35npk6c) (pioglitazone - unii:x4ov71u42s) - monotherapy and combination therapy pioglitazone tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings [see clinical studies (14)] . important limitations of use pioglitazone tablet exerts its antihyperglycemic effect only in the presence of endogenous insulin. pioglitazone tablets should not be used to treat type 1 diabetes or diabetic ketoacidosis, as it would not be effective in these settings. use caution in patients with liver disease [see warnings and precautions (5.3)] . initiation in patients with established nyha class iii or iv heart failure [see boxed warning]. use in patients with known hypersensitivity to pioglitazone or any other component of pioglitazone tablets. 8.1 pregnancy risk summary limited data with pioglitazone hydrochloride in pregnant women are not sufficient to determine a drug-associated risk for major birth defects or miscarriage. there are risks to the mother and fetus a

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

dispensing solutions, inc. - pioglitazone hydrochloride (unii: jqt35npk6c) (pioglitazone - unii:x4ov71u42s) - pioglitazone hydrochloride 15 mg - actos is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings [see clinical studies (14)] . actos exerts its antihyperglycemic effect only in the presence of endogenous insulin. actos should not be used to treat type 1 diabetes or diabetic ketoacidosis, as it would not be effective in these settings. use caution in patients with liver disease [see warnings and precautions (5.3)] . do not initiate in patients with nyha class iii or iv heart failure [see boxed warning] . do not use in patients with a history of a serious hypersensitivity reaction to actos or any of its ingredients. pregnancy category c. there are no adequate and well-controlled studies of actos in pregnant women. animal studies show increased rates of post-implantation loss, delayed development, reduced fetal weights, and delayed parturition at doses 10 to 40 times the maximum recommended human dose. actos should be used during pregnancy only if the p

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

physicians total care, inc. - pioglitazone hydrochloride (unii: jqt35npk6c) (pioglitazone - unii:x4ov71u42s) - pioglitazone hydrochloride 15 mg - actos is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings [see clinical studies (14)] . actos exerts its antihyperglycemic effect only in the presence of endogenous insulin. actos should not be used to treat type 1 diabetes or diabetic ketoacidosis, as it would not be effective in these settings. use caution in patients with liver disease [see warnings and precautions (5.3)] . do not initiate in patients with nyha class iii or iv heart failure [see boxed warning] . do not use in patients with a history of a serious hypersensitivity reaction to actos or any of its ingredients. pregnancy category c. there are no adequate and well-controlled studies of actos in pregnant women. animal studies show increased rates of post-implantation loss, delayed development, reduced fetal weights, and delayed parturition at doses 10 to 40 times the maximum recommended human dose. actos should be used during pregnancy only if the p

Australija - anglų - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - pioglitazone hydrochloride -

Australija - anglų - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - pioglitazone hydrochloride -